LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 10 of 15: Cell count and normalized growth rate inhibition values within biological replicate 3. - Dataset (ID:20247)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
SK-BR-3 | uM | LJP5 | 3 | N23 | 72 | hr | 1401 | 4269 | 4545 | 0.9391 | 0.9273 | ||
SK-BR-3 | uM | LJP5 | 3 | N24 | 72 | hr | 1401 | 4124 | 4545 | 0.9072 | 0.8885 | ||
MDA-MB-231 | Seliciclib | 0.04 | uM | LJP5 | 1 | J06 | 72 | hr | 1235 | 4349 | 4474 | 0.9719 | 0.9695 |
MDA-MB-231 | Seliciclib | 0.04 | uM | LJP5 | 2 | J06 | 72 | hr | 1235 | 4488 | 4578 | 0.9802 | 0.9790 |
MDA-MB-231 | Seliciclib | 0.04 | uM | LJP5 | 3 | J06 | 72 | hr | 1235 | 5141 | 4929 | 1.0430 | 1.0426 |
MDA-MB-231 | Seliciclib | 0.12 | uM | LJP5 | 1 | J05 | 72 | hr | 1235 | 4019 | 4474 | 0.8982 | 0.8876 |
MDA-MB-231 | Seliciclib | 0.12 | uM | LJP5 | 2 | J05 | 72 | hr | 1235 | 4403 | 4578 | 0.9617 | 0.9590 |
MDA-MB-231 | Seliciclib | 0.12 | uM | LJP5 | 3 | J05 | 72 | hr | 1235 | 4751 | 4929 | 0.9638 | 0.9634 |
MDA-MB-231 | Seliciclib | 0.37 | uM | LJP5 | 1 | J04 | 72 | hr | 1235 | 4119 | 4474 | 0.9205 | 0.9127 |
MDA-MB-231 | Seliciclib | 0.37 | uM | LJP5 | 2 | J04 | 72 | hr | 1235 | 4324 | 4578 | 0.9444 | 0.9404 |
MDA-MB-231 | Seliciclib | 0.37 | uM | LJP5 | 3 | J04 | 72 | hr | 1235 | 4664 | 4929 | 0.9462 | 0.9453 |
MDA-MB-231 | Seliciclib | 1.11 | uM | LJP5 | 1 | J03 | 72 | hr | 1235 | 3745 | 4474 | 0.8369 | 0.8171 |
MDA-MB-231 | Seliciclib | 1.11 | uM | LJP5 | 2 | J03 | 72 | hr | 1235 | 4032 | 4578 | 0.8806 | 0.8699 |
MDA-MB-231 | Seliciclib | 1.11 | uM | LJP5 | 3 | J03 | 72 | hr | 1235 | 4573 | 4929 | 0.9277 | 0.9262 |
MDA-MB-231 | Seliciclib | 3.33 | uM | LJP5 | 1 | J02 | 72 | hr | 1235 | 3463 | 4474 | 0.7739 | 0.7421 |
MDA-MB-231 | Seliciclib | 3.33 | uM | LJP5 | 2 | J02 | 72 | hr | 1235 | 3698 | 4578 | 0.8077 | 0.7862 |
MDA-MB-231 | Seliciclib | 3.33 | uM | LJP5 | 3 | J02 | 72 | hr | 1235 | 4103 | 4929 | 0.8324 | 0.8243 |
MDA-MB-231 | Seliciclib | 10 | uM | LJP5 | 1 | J01 | 72 | hr | 1235 | 2296 | 4474 | 0.5131 | 0.3961 |
MDA-MB-231 | Seliciclib | 10 | uM | LJP5 | 2 | J01 | 72 | hr | 1235 | 2364 | 4578 | 0.5163 | 0.4095 |
MDA-MB-231 | Seliciclib | 10 | uM | LJP5 | 3 | J01 | 72 | hr | 1235 | 2730 | 4929 | 0.5538 | 0.4875 |
MDA-MB-231 | AT-7519 | 0.04 | uM | LJP6 | 1 | K06 | 72 | hr | 1235 | 2685 | 4355 | 0.6164 | 0.5325 |
MDA-MB-231 | AT-7519 | 0.04 | uM | LJP6 | 2 | K06 | 72 | hr | 1235 | 2631 | 4277 | 0.6151 | 0.5247 |
MDA-MB-231 | AT-7519 | 0.04 | uM | LJP6 | 3 | K06 | 72 | hr | 1235 | 2664 | 4583 | 0.5812 | 0.5011 |
MDA-MB-231 | AT-7519 | 0.12 | uM | LJP6 | 1 | K05 | 72 | hr | 1235 | 1114 | 4355 | 0.2557 | -0.0556 |
MDA-MB-231 | AT-7519 | 0.12 | uM | LJP6 | 2 | K05 | 72 | hr | 1235 | 739 | 4277 | 0.1728 | -0.2496 |